PLoS ONE
(Jan 2023)
Testing a new platform to screen disease-modifying therapy in type 1 diabetes
- Sandra M. Lord,
- Henry T. Bahnson,
- Carla J. Greenbaum,
- David R. Liljenquist,
- John Virostko,
- Cate Speake
Affiliations
- Sandra M. Lord
- Henry T. Bahnson
- Carla J. Greenbaum
- David R. Liljenquist
- John Virostko
- Cate Speake
- Journal volume & issue
-
Vol. 18,
no. 12
WeChat QR code